Itamar Medical itamar-medical.com


Public lists: Medical Devices (6162)

Develops a minimally invasive diagnostic that measures through a finger probe the Peripheral Arterial Tone (PAT) signal. The Itamar device is approved for the diagnosis of sleep apnea and as an indicator of endothelial dysfunction. Itamar completed an Initial Public Offering in March 2007 (TASE:ITMR).

Develops a minimally invasive diagnostic that measures through a finger probe the Peripheral Arterial Tone (PAT) signal. The Itamar device is approved for the diagnosis of sleep apnea and as an indicator of endothelial dysfunction. Itamar completed a...Show all

Company (Alive / Active)

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Itamar Medical $0M Apr 19, 2019
See all 15 competitors

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Itamar Medical Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 1 investors
There is no Board of Directors data available for this company. Please select another tab.

Competitors

Company Status Description Investors

Apnex Medical

Saint Paul, Minnesota, United States
Dead / InactiveApnex Medical is focused on helping to improve the health of people with sleep disordered breathing. Apnex is developing an active implantable medical device for the treatment of obstructive sleep apnea (OSA). This disorder is associated with significant long-term health problems.Login to see details

Intact Medical

Framingham, Massachusetts, United States
Alive / ActiveIntact Medical markets, designs, and develops minimally invasive systems for the volumetric excision of tissue for diagnostic and therapeutic applications in select cancer markets. Initial products will be targeted at breast biopsy.Login to see details
See all 15 competitors